In line with our mouse data, CB1 and CB2 expression were not only seen in lung cancer cells, but also in infiltrated immune cells, such as CD3+ T and CD8+ T cells, NKp46/NCR1+or CD56+ NK cells, and CD163+ macrophages. Here, CD163 is linked to lung carcinoma.